The tissue-specific distribution of ³H-seocalcitol (EB 1089) and ³H-calcitriol in ratsKISSMEYER, Anne-Marie; NIELSEN, Jeanet Løgsted; BINDERUP, Lise et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 89-90, Num 1-5, pp 43-47, issn 0960-0760, 5 p.Conference Paper

Histone Acetylation in Keratinocytes Enables Control of the Expression of Cathelicidin and CD14 by 1,25-Dihydroxyvitamin D₃. CommentarySEGAERT, Siegfried; SCHAUBER, Jürgen; ODA, Yuko et al.Journal of investigative dermatology. 2008, Vol 128, Num 4, issn 0022-202X, 816-824, 773-775 [12 p.]Article

Why Vitamin D is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoidsVIETH, Reinhold.Journal of steroid biochemistry and molecular biology. 2004, Vol 89-90, Num 1-5, pp 571-573, issn 0960-0760, 3 p.Conference Paper

Regulation of the epithelial Ca²⁺ channels TRPV5 and TRPV6 by 1α, 25-dihydroxy Vitamin D₃ and dietary Ca²⁺VAN DE GRAAF, Stan F. J; BOULLART, Inge; HOENDEROP, Joost G. J et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 89-90, Num 1-5, pp 303-308, issn 0960-0760, 6 p.Conference Paper

Association of calcitriol and blood pressure in normotensive menKRISTAL-BONEH, E; FROOM, P; HARARI, G et al.Hypertension (Dallas, Tex. 1979). 1997, Vol 30, Num 5, pp 1289-1294, issn 0194-911XArticle

Conversion of vitamin D₃ to 1α, 25-dihydroxyvitamin D₃ in human skin equivalentsLEHMANN, B; RUDOLPH, T; PIETZSCH, J et al.Experimental dermatology. 2000, Vol 9, Num 2, pp 97-103, issn 0906-6705Article

Topical calcitriol is degraded by ultraviolet light. CommentaryLEBWOHL, Mark; QUIJIJE, John; GILLIARD, Jean et al.Journal of investigative dermatology. 2003, Vol 121, Num 3, pp xiii-xiv, issn 0022-202X, 4 p.Article

Resolution of Granular Parakeratosis With Topical CalcitriolPATEL, Urvi; PATEL, Tejesh; SKINNER, Robert B et al.Archives of dermatology (1960). 2011, Vol 147, Num 8, pp 997-998, issn 0003-987X, 2 p.Article

CYP24A1 Inhibition Enhances the Antitumor Activity of CalcitriolMUINDI, Josephia R; YU, Wei-Dong; YINGYU MA et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 9, pp 4301-4312, issn 0013-7227, 12 p.Article

Methyl-introduced A-ring analogues of 1α,25-dihydroxyvitamin D₃ : Synthesis and biological evaluationFUJISHIMA, Toshie; TSUTSUMI, Ryuji; NEGISHI, Yoichi et al.Anticancer research. 2006, Vol 26, Num 4A, pp 2633-2636, issn 0250-7005, 4 p.Conference Paper

Idiopathic calcitriol-induced hypercalcemia : A new disease entity?EVRON, E; GOLAND, S; VON DER WALDE, J et al.Archives of internal medicine (1960). 1997, Vol 157, Num 18, pp 2142-2145, issn 0003-9926Article

Granuloma annulare responsive to oral calcitriolBOYD, Alan S; BOYD, Alan S.BOYD, Alan S; BOYD, Alan S.International journal of dermatology. 2012, Vol 51, Num 1, pp 120-122, issn 0011-9059, 3 p.Article

1α,25-dihydroxyvitamin D₃ modulates the response of human keratinocytes to ionizing radiation exposureMÜLLER, Kerstin; SCHINN, Michaela; REICHRATH, Jörg et al.Anticancer research. 2006, Vol 26, Num 4A, pp 2735-2741, issn 0250-7005, 7 p.Conference Paper

Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal womenTFELT-HANSEN, J; SCHWARZ, P; TORRING, O et al.Scandinavian journal of clinical & laboratory investigation. 2001, Vol 61, Num 5, pp 395-400, issn 0036-5513Article

Treatment of Linear scleroderma with oral 1,25-dihydroxyvitamin D₃ (calcitriol) in seven childrenELST, E. F; VAN SUIJLEKOM-SMIT, L. W. A; ORANJE, A. P et al.Pediatric dermatology. 1999, Vol 16, Num 1, pp 53-58, issn 0736-8046Article

Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adultsBHAN, Ishir; CAMARGO, Carlos A; WENGER, Julia et al.Journal of allergy and clinical immunology. 2011, Vol 127, Num 5, pp 1302-1304, issn 0091-6749, 3 p.Article

Calcitriol Ointment: Optimizing Psoriasis TherapySTEIN GOLD, Linda E.Journal of drugs in dermatology. 2009, Vol 8, Num 8, issn 1545-9616, s23-s27, SUPArticle

Effect of 1,25-dihydroxyvitamin D₃ and calcium carbonate on bone loss associated with long-term renal transplantationCUETO-MANZANO, A. M; KONEL, S; FREEMONT, A. J et al.American journal of kidney diseases. 2000, Vol 35, Num 2, pp 227-236, issn 0272-6386Article

Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D₃ than by vitamin D₃THEILER, R; BISCHOFF, H; TYNDALL, A et al.International journal for vitamin and nutrition research. 1998, Vol 68, Num 1, pp 36-41, issn 0300-9831Article

Topical calcitriol (1,25-dihydroxyvitamin D₃) treatment of psoriasis : An immunohistological evaluationREICHRATH, J; PEREZ, A; MÜLLER, S. M et al.Acta dermato-venereologica. 1997, Vol 77, Num 4, pp 268-272, issn 0001-5555Article

Regulation of branchial zinc uptake by 1α,25-(OH)₂D₃ in rainbow trout and associated changes in expression of ZIP1 and ECaCANDONG QIU; GLOVER, Chris N; HOGSTRAND, Christer et al.Aquatic toxicology. 2007, Vol 84, Num 2, pp 142-152, issn 0166-445X, 11 p.Conference Paper

Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosisFLYNN, Geraldine; CHUNG, Ivy; YU, Wei-Dong et al.Oncology. 2006, Vol 70, Num 6, pp 447-457, issn 0030-2414, 11 p.Article

Impaired nuclear localization of vitamin D receptor in leukemia cells resistant to calcitriol-induced differentiationHUMENIUK-POLACZEK, Rita; MARCINKOWSKA, Ewa.Journal of steroid biochemistry and molecular biology. 2004, Vol 88, Num 4-5, pp 361-366, issn 0960-0760, 6 p.Article

Efficacy and Safety of Topical Calcitriol 3 μg/g Ointment, A New Topical Therapy for Chronic Plaque PsoriasisKIRCIK, Leon.Journal of drugs in dermatology. 2009, Vol 8, Num 8, issn 1545-9616, s9-s16, SUPArticle

Calcitriol 3 μg/g Ointment: An Effective and Safe Addition to the Armamentarium in Topical Psoriasis TherapyABRAMOVITS, William.Journal of drugs in dermatology. 2009, Vol 8, Num 8, issn 1545-9616, s17-s22, SUPArticle